St. Louis Trust CO Intra Cellular Therapies, Inc. Transaction History

St. Louis Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$44.07 - $54.45 $220,350 - $272,250	5,000 New	5,000 $264,000
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $304,883 - $488,648	-7,870 Reduced 61.15%	5,000 $306,000
Q4 2021 Feb 07, 2022	BUY	$35.2 - $53.42 $453,024 - $687,515	12,870 New	12,870 $674,000
Q3 2021 Nov 12, 2021	SELL	$28.72 - $42.49 $143,600 - $212,450	-5,000 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$29.3 - $44.5 $146,500 - $222,500	5,000 New	5,000 $204,000
Q3 2020 Oct 27, 2020	SELL	$17.61 - $31.86 $15.5 Million - $28.1 Million	-881,056 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$12.31 - $33.12 $10.8 Million - $29.2 Million	881,056 New	881,056 $13.5 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of St. Louis Trust CO, based on Form 13F filings with the SEC.

Stay updated on St. Louis Trust CO with notifications on news.